AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Esposito, S Noviello, S Ianniello, F D'Errico, G
Citation: S. Esposito et al., Short-course therapy with cefaclor for treatment of streptococcal pharyngotonsillitis, INT J ANT A, 18(4), 2001, pp. 341-345

Authors: Noviello, S Ianniello, F Esposito, S
Citation: S. Noviello et al., In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci, J ANTIMICRO, 48(2), 2001, pp. 283-286

Authors: Esposito, S Noviello, S Ianniello, F
Citation: S. Esposito et al., Activity of moxifloxacin and twelve other antimicrobial agents against 216clinical isolates of Streptococcus pneumoniae, CHEMOTHERA, 47(2), 2001, pp. 90-96

Authors: Esposito, S Noviello, S Ianniello, F
Citation: S. Esposito et al., Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model, J CHEMOTHER, 12(6), 2000, pp. 475-481

Authors: Esposito, S Noviello, S Ianniello, F D'Errico, G
Citation: S. Esposito et al., Ceftazidime for outpatient parenteral antibiotic therapy (OPAT) of chronicsuppurative otitis media due to Pseudomonas aeruginosa, J CHEMOTHER, 12(1), 2000, pp. 88-93

Authors: Esposito, S Noviello, S Ianniello, F
Citation: S. Esposito et al., Comparative in vitro activity of cider and newer fluoroquinolones against respiratory tract pathogens, CHEMOTHERA, 46(5), 2000, pp. 309-314

Authors: Esposito, S Noviello, S Ianniello, F Novelli, A
Citation: S. Esposito et al., In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic Streptococcus, CHEMOTHERA, 46(1), 2000, pp. 23-27
Risultati: 1-7 |